1. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Annex to Directive 2001/83 / EC - Module 4 "Pre-clinical study report" https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32001L0083.
2. GLP: Good Laboratory Practice, Nov. 2011 DOI:10.1007/978-3-211-89836-9_613 Standards for laboratory investigations; GLP principles are defined by the EC (I) as: ..úprinciples of good laboratory practice, that are consistent with the OECD principles of good laboratory practice as adopted in article 1 of directive 87/18/EEC..Ñ..
3. International Conference on Harmonisation (2009). Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals M3(R2). Step 5 Geneva: ICH. Retrieved 11 July, 2021, from https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m3r2-non-clinical-safety-studies-conduct-human-clinical-trials-marketing-authorisation_en.pdf.
4. Health technology assessment bodies | European medicines agency, (n.d.). https://www.infarma.pl/innowacje/jak-powstaja-leki/ (accessed May 26, 2022).
5. The chemoresistance of human malignant melanoma: an update;Serrone;Melanoma Res.,1999